知镜 Cognispect · 医学文献与研究工作台

Universal-labeled recombinase polymerase amplification coupled with lateral flow assay for simultaneous detection of Acinetobacter baumannii and its resistance gene.

Liu H, Wang Z, Zhou Y, Zhang S, Jia Y, Liu S, Li Z, Hao R.
Analytica chimica acta · 2026-09-13 · PMID 42951511

文献摘要

Acinetobacter baumannii is a WHO critical-priority pathogen whose clinical threat is dramatically exacerbated by carbapenem-resistant strains (CRAB) harboring bla OXA-23. Simultaneous identification of this pathogen and its resistance determinant under field conditions remains an unmet clinical need. Here we report a universal-labeled recombinase polymerase amplification coupled with lateral flow assay (UL-RALA) for simultaneous, sensitive detection of A. baumannii (recA) and its resistance gene bla OXA-23 from clinical sputum. Chimeric tailed primers enable a single universal labeled primer-probe set to amplify both targets, eliminating target-specific probes and suppressing cross-reactivity. Streptavidin-conjugated quantum dot nano-labels deliver independent FAM/recA and DIG/bla OXA-23 fluorescent readouts without signal crosstalk. Under optimized conditions, the platform achieves a limit of detection of 1 copy/μL for both target nucleic acids within 15 min. The outcomes of the clinical validation serve as a strong proof-of-concept for our proposed platform. This modular, platform provides a promising platform for rapid dual-profiling of CRAB infections at the point of care. The modular architecture and encoding-free probe strategy of this UL-RALA methodology It could also provide a highly adaptable, and scalable blueprint for the rapid, on-site diagnostic screening of other emerging infectious pathogens and their associated antimicrobial resistance profiles.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。